Dapagliflozin ameliorates Alzheimer’s disease in rats via stimulating the protective arm of renin angiotensin system and suppressing neuroinflammation

Zeinab M Awwad · 2026

Read Dapagliflozin ameliorates Alzheimer’s disease in rats via stimulating the protective arm of renin angiotensin system and suppressing neuroinflammation by Zeinab M Awwad (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13525001.txt.

Description

Zeinab M. Awwad reports, in a 2026 rat study, that the diabetes drug dapagliflozin eased Alzheimer's-like disease induced by scopolamine. In Alzheimer's, the renin-angiotensin system, a hormone network, runs too hot on its harmful arm, which drives amyloid damage, while a helpful arm with ACE2 and a small peptide counters it. The drug was meant to reset the balance between the arms.

Treated rats showed lower ACE, angiotensin II, and its harmful receptor in the hippocampus, with higher ACE2, the helpful peptide, and its receptor, plus boosted signaling through a survival pathway. Death and inflammation markers fell, tissue damage eased, and scores improved in object and maze alternation tests of learning and memory. Awwad presents the results as first findings for this helpful mechanism against cognitive deficits.

Catalog record

CREATORZeinab M Awwad
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33105
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13525001

Browse the full library · About the Tower of Babel